全文获取类型
收费全文 | 2344篇 |
免费 | 116篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 18篇 |
妇产科学 | 8篇 |
基础医学 | 269篇 |
口腔科学 | 28篇 |
临床医学 | 159篇 |
内科学 | 744篇 |
皮肤病学 | 41篇 |
神经病学 | 161篇 |
特种医学 | 58篇 |
外科学 | 504篇 |
综合类 | 4篇 |
预防医学 | 41篇 |
眼科学 | 12篇 |
药学 | 123篇 |
中国医学 | 5篇 |
肿瘤学 | 261篇 |
出版年
2024年 | 3篇 |
2023年 | 18篇 |
2022年 | 32篇 |
2021年 | 63篇 |
2020年 | 51篇 |
2019年 | 53篇 |
2018年 | 61篇 |
2017年 | 61篇 |
2016年 | 63篇 |
2015年 | 62篇 |
2014年 | 75篇 |
2013年 | 71篇 |
2012年 | 124篇 |
2011年 | 155篇 |
2010年 | 94篇 |
2009年 | 47篇 |
2008年 | 122篇 |
2007年 | 129篇 |
2006年 | 148篇 |
2005年 | 137篇 |
2004年 | 134篇 |
2003年 | 104篇 |
2002年 | 105篇 |
2001年 | 35篇 |
2000年 | 28篇 |
1999年 | 39篇 |
1998年 | 29篇 |
1997年 | 16篇 |
1996年 | 20篇 |
1995年 | 18篇 |
1994年 | 15篇 |
1993年 | 7篇 |
1992年 | 22篇 |
1991年 | 21篇 |
1990年 | 20篇 |
1989年 | 31篇 |
1988年 | 27篇 |
1987年 | 50篇 |
1986年 | 40篇 |
1985年 | 31篇 |
1984年 | 27篇 |
1983年 | 17篇 |
1982年 | 7篇 |
1981年 | 13篇 |
1980年 | 9篇 |
1979年 | 13篇 |
1978年 | 5篇 |
1977年 | 17篇 |
1976年 | 3篇 |
1975年 | 3篇 |
排序方式: 共有2480条查询结果,搜索用时 15 毫秒
81.
Tomonori Aoki Atsuo Yamada Kazuharu Aoyama Hiroaki Saito Gota Fujisawa Nariaki Odawara Ryo Kondo Akiyoshi Tsuboi Rei Ishibashi Ayako Nakada Ryota Niikura Mitsuhiro Fujishiro Shiro Oka Soichiro Ishihara Tomoki Matsuda Masato Nakahori Shinji Tanaka Kazuhiko Koike Tomohiro Tada 《Digestive endoscopy》2020,32(4):585-591
82.
Tomoyuki Fujita Takashi Kakuta Naonori Kawamoto Yusuke Shimahara Shin Yajima Naoki Tadokoro Soichiro Kitamura Junjiro Kobayashi Satsuki Fukushima 《Interactive Cardiovascular and Thoracic Surgery》2021,32(3):417
OBJECTIVESTo determine whether robotic mitral valve repair can be applied to more complex lesions compared with minimally invasive direct mitral valve repair through a right thoracotomy. Open in a separate windowMETHODSWe enrolled 335 patients over a 9-year period; 95% of the robotic surgeries were performed after experience performing direct mitral valve repair.RESULTSThe mean age in the robotic versus thoracotomy repair groups was 61 ± 14 vs 55 ± 11 years, respectively (P < 0.001); 97% vs 100% of the patients, respectively, had degenerative aetiologies. Repair complexity was simple in 106 (63%) vs 140 (84%), complex in 34 (20%) vs 20 (12%) and most complex in 29 (17%) vs 6 (4%) patients undergoing robotic versus thoracotomy repair, respectively. The average complexity score with robotic repair was significantly higher versus thoracotomy repair (P < 0.001). The robotic group underwent more chordal replacement using polytetrafluoroethylene and less resections. All patients underwent ring annuloplasty. Cross-clamp time did not differ between the groups, and no strokes or deaths occurred. More patients undergoing robotic repair underwent concomitant procedures versus the thoracotomy group (30% vs 14%, respectively; P < 0.001). The overall repair rate was 100%, with no early mortality or strokes in either group. Postoperative mean residual mitral regurgitation was 0.3 in both groups, and the mean pressure gradient through the mitral valve was 2.4 vs 2.7 mmHg (robotic versus thoracotomy repair, respectively; P = 0.031).CONCLUSIONSRobotic surgery can be applied to repair more complex mitral lesions, with excellent early outcomes. 相似文献
83.
Manabu Fujimoto Jun Asai Yoshihide Asano Takayuki Ishii Yohei Iwata Tamihiro Kawakami Masanari Kodera Masatoshi Abe Masahiro Amano Ryuta Ikegami Taiki Isei Zenzo Isogai Takaaki Ito Yuji Inoue Ryokichi Irisawa Masaki Ohtsuka Yoichi Omoto Hiroshi Kato Takafumi Kadono Sakae Kaneko Hiroyuki Kanoh Masakazu Kawaguchi Ryuichi Kukino Takeshi Kono Monji Koga Keisuke Sakai Eiichi Sakurai Yasuko Sarayama Yoichi Shintani Miki Tanioka Hideaki Tanizaki Jun Tsujita Naotaka Doi Takeshi Nakanishi Akira Hashimoto Minoru Hasegawa Masahiro Hayashi Kuninori Hirosaki Hideki Fujita Hiroshi Fujiwara Takeo Maekawa Koma Matsuo Naoki Madokoro Sei-Ichiro Motegi Hiroshi Yatsushiro Osamu Yamasaki Yuichiro Yoshino Andres James LE Pavoux Takao Tachibana Hironobu Ihn Japanese Dermatological Association Guidelines 《The Journal of dermatology》2020,47(10):1071-1109
The Japanese Dermatological Association prepared guidelines focused on the treatment of skin ulcers associated with connective tissue disease/vasculitis practical in clinical settings of dermatological care. Skin ulcers associated with connective tissue diseases or vasculitis occur on the background of a wide variety of diseases including, typically, systemic sclerosis but also systemic lupus erythematosus (SLE), dermatomyositis, rheumatoid arthritis (RA), various vasculitides and antiphospholipid antibody syndrome (APS). Therefore, in preparing the present guidelines, we considered diagnostic/therapeutic approaches appropriate for each of these disorders to be necessary and developed algorithms and clinical questions for systemic sclerosis, SLE, dermatomyositis, RA, vasculitis and APS. 相似文献
84.
Hiroaki Soyama Morikazu Miyamoto Hiroko Matsuura Hideki Iwahashi Soichiro Kakimoto Hiroki Ishibashi Takahiro Sakamoto Taira Hada Jin Suminokura Masashi Takano 《Cancer chemotherapy and pharmacology》2020,85(5):941-947
The aim of this study was to investigate the association between changes in the levels of vascular endothelial growth factors (VEGFs) after treatment with bevacizumab and gemcitabine (Bev-Gem) and the clinical outcome. Platinum-resistant ovarian cancer patients treated with Bev-Gem therapy at our hospital between 2014 and 2018 were identified. Serum VEGF levels at the first and second treatment cycle were measured by ELISA. All patients were categorized into two groups—patients with > 50% decrease in serum VEGF-A levels (Group A) and patients with < 50% decrease serum VEGF-A levels (Group B). The association between clinical outcome and serum VEGF levels was investigated between the two groups. Among 18 patients, 10 were in Group A and 8 in Group B. Group A exhibited a lower response rate (0% vs.75% p < 0.01) and clinical benefit rate (60% vs.100% p = 0.02) than Group B. The median serum VEGF-A level of Group A before the first cycle of Bev-Gem therapy was higher than that in Group B (61.2 vs. 3.7 pg/mL, p < 0.01). Group A exhibited worse PFS (7 vs., 10 months, p < 0.01) and OS (17 vs. 26 months, p = 0.04) than Group B. There were more patients with > 10% increase in serum VEGF-B levels in Group A than in Group B (p < 0.01). The rapid decrease in VEGF-A levels and the resultant increase in serum VEGF-B levels might be associated with an unfavorable clinical outcome. Large-scale studies are needed to further examine these results. 相似文献
85.
Impact of left atrial size on isolation area in the acute phase of pulmonary vein isolation using 28 mm cryoballoon 下载免费PDF全文
Akio Chikata MD PhD Takeshi Kato MD PhD Kazuo Usuda MD PhD Shuhei Fujita MD PhD Michiro Maruyama MD PhD Yoshiki Nagata MD PhD Satoru Sakagami MD PhD Naomi Kanamori MD Takanori Yaegashi MD PhD Takahiro Saeki MD PhD Takashi Kusayama MD PhD Soichiro Usui MD PhD Hiroshi Furusho MD PhD Shuichi Kaneko MD PhD Masayuki Takamura MD PhD 《Pacing and clinical electrophysiology : PACE》2018,41(7):700-706
86.
Yasufumi Masaki Hiroshi Kawabata Kazue Takai Masaru Kojima Norifumi Tsukamoto Yasuhito Ishigaki Nozomu Kurose Makoto Ide Jun Murakami Kenji Nara Hiroshi Yamamoto Yoko Ozawa Hidekazu Takahashi Katsuhiro Miura Tsutomu Miyauchi Shinichirou Yoshida Akihito Momoi Nobuyasu Awano Soichiro Ikushima Yasunori Ohta Natsue Furuta Shino Fujimoto Haruka Kawanami Tomoyuki Sakai Takafumi Kawanami Yoshimasa Fujita Toshihiro Fukushima Shigeo Nakamura Tomohiro Kinoshita Sadao Aoki 《International journal of hematology》2016,103(6):686-692
87.
88.
M Nishikibe H Ohta M Okada K Ishikawa T Hayama T Fukuroda K Noguchi M Saito T Kanoh S Ozaki T Kamei K Hara D William S Kivlighn S Krause R Gabel G Zingaro N Nolan J O'Brien F Clayton J Lynch D Pettibone P Siegl 《The Journal of pharmacology and experimental therapeutics》1999,289(3):1262-1270
J-104132 [(+)-(5S,6R, 7R)-2-butyl-7-[2-((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3, 4-methylenedioxyphenyl)cyclopenteno[1,2-b]pyridine-6-carboxylic; also referred to as L-753,037] is a potent, selective inhibitor of ETA and ETB endothelin (ET) receptors (e.g., Ki: cloned human ETA = 0.034 nM; cloned human ETB = 0.104 nM). In both ligand-binding and isolated tissue preparation protocols, the inhibition of ET receptors with J-104132 is reversible and competitive. In vitro, J-104132 is a potent antagonist of ET-1-induced accumulation of [3H]inositol phosphates in Chinese hamster ovary cells stably expressing cloned human ETA receptors (IC50 = 0.059 nM), ET-1-induced contractions in rabbit iliac artery (pA2 = 9.70) and of BQ-3020-induced contractions in pulmonary artery (pA2 = 10.14). J-104132 is selective for ET receptors because it had no effect on contractions elicited by norepinephrine or KCl in the vascular preparations. The in vivo potency of J-104132 was assessed using challenges with exogenous ET-1. In conscious mice, 5 nmol/kg i.v. ET-1 causes death. Pretreatment with J-104132 prevents the lethal response to ET-1 when administered i.v. (ED50 = 0.045 mg/kg) or p.o. in fed animals (ED50 = 0.35 mg/kg). In conscious, normotensive rats, pressor responses to 0.5 nmol/kg i.v. ET-1 are inhibited by J-104132 after i.v. (0.1 mg/kg) or p.o. (1 mg/kg) administration. In anesthetized dogs, ET-1 was administered directly into the renal artery or brachial artery to generate dose-response (blood flow) curves, and the inhibitory potency of J-104132 (i.v. infusion) was quantified. J-104132 produced greater than 10-fold shifts in the ET-1 dose-response curves at 0.03 mg/kg/h (renal) and 0.3 mg/kg/h (brachial). Oral bioavailability of J-104132 in rats was approximately 40%. These studies indicate that J-104132 is a selective, potent, orally active antagonist of both ETA and ETB receptors and is an excellent pharmacological tool to explore the therapeutic use of a mixed ETA/ETB receptor antagonist. 相似文献
89.
Motonori Saku Soichiro Maekawa Koji Ikejiri Shigeru Yakabe Hideaki Anai Koji Yoshida 《Surgery today》1995,25(3):284-286
We describe herein a new and successful method of performing a safe and steady one-stage operation for completely obstructive colorectal carcinoma. First, a long ileus tube is utilized to decompress the dilated proximal bowel preoperatively and irrigate the feces-loaded colon intraoperatively. Following this procedure, a standard resection with radical lymph node dissection is carried out without a diverting colostomy. We performed this procedure successfully in seven patients, none of whom developed any anastomotic leakage. 相似文献
90.
Kim J Washio T Yamagishi M Yasumura Y Nakatani S Hashimura K Hanatani A Komamura K Miyatake K Kitamura S Tomoike H Kitakaze M 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2004,18(6):483-489
Summary Background: Data mining is a technique for discovering useful information hidden in a database, which has recently been used by the chemical, financial, pharmaceutical, and insurance industries. It may enable us to detect the interesting and hidden data on useful drugs especially in the field of cardiovascular disease.Methods: & Results: We evaluated the current treatments for chronic heart failure (CHF) in our institute using a decision tree method of data mining and compared the results with those of large-scale clinical trials. We enrolled 1,100 patients with CHF (NYHA classes II–IV and EF < 40%) who were hospitalized at the National Cardiovascular Center during the past 31 months. Drugs prescribed at discharge were extracted from the clinical database. Both echocardiograms and plasma BNP level at 6–12 months after discharge were determined prospectively. It was found that beta-blockers, angiotensin converting enzyme inhibitors, and angiotensin II receptor antagonists independently improve both the plasma BNP level and %fractional shortening (FS), while oral inotropic agents increased the plasma BNP level and decreased %FS. These findings agree with evidence accumulated from several large-scale trials. Interestingly, statins, histamine receptor blockers, and alpha-glucosidase inhibitors also attenuated the severity of CHF, suggesting the possibility of new treatment of CHF.Conclusion: Clinical data mining using Japanese CHF patients yielded almost identical data to the results of large-scale trials, and also suggested novel and unexpected candidates for CHF therapy. Further validation of the data mining approved in the cardiovascular field is warranted. 相似文献